Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

KYTH 36.73 0.00 (0.00%)
price chart
Kythera Biopharmaceuticals Inc Insider Trading Update
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), The Director, of KYTHERA Biopharmaceuticals Inc, Samuels Camille D had unloaded 250 shares at $36.7 per share in a transaction on January 16, 2015.
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
WESTLAKE VILLAGE, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on January 16, 2015, the Compensation Committee of the Company's Board of Directors granted four new ...
Short Interest of Kythera Biopharmaceuticals Inc Drops by 0.2%  Stafford Daily
KYTHERA Biopharmaceuticals Announces Date of FDA Advisory Committee ...
KYTHERA Biopharmaceuticals, Inc. KYTH, -0.82% today announced the Dermatology and Ophthalmic Drugs Advisory Committee of the U.S.
Double Chin? There May Be a Drug for That  Bloomberg
Monday Stock Updates: SemiLEDs Corp , TubeMogul Inc , KYTHERA ...
KYTHERA Biopharmaceuticals Inc (KYTH) gained 1.45 points to close 4.1100% higher. The session began with the first transaction at 35.15 and the price swung wildly to hit a low of 35.04 and a high of 36.86.
Kythera Biopharmaceuticals Inc Reports Insider Transaction
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), The Securities and Exchange Commission has divulged that David Nathaniel E, Director of KYTHERA Biopharmaceuticals Inc, had unloaded 1,680 shares at an average price of $35.3 in a transaction dated ...
KYTHERA Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan ...
WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the 33rd Annual J.P.
KYTHERA Biopharmaceuticals to Present at the Goldman Sachs US Emerging ...
WESTLAKE VILLAGE, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs US Emerging / SMID Cap ...
Related articles »  
KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors
WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has named Hollings C. Renton to its Board of Directors.
Related articles »  
KYTHERA Biopharmaceuticals Releases Third Quarter 2014 Operating Results
WESTLAKE VILLAGE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2014 and provided an update on recent accomplishments.
Kythera Biopharmaceuticals Price Target Cut to $59.00 by Analysts at FBR ...  sleekmoney
Kythera Biopharmaceuticals Given New $59.00 Price Target at FBR Capital ...  WKRB News
Related articles »  
KYTHERA Biopharmaceuticals Announces Third Quarter 2013 Operating Results
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.
Related articles »